Wyche Fowler, Director at KERYX BIOPHARMACEUTICALS INC (KERX), bought 20,000 shares at $1.05 ($21K) on 2009-06-04, disclosed to the SEC on 2009-06-04.
Open-market purchase of $21k KERX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KERX | BUY | 2011-08-11 | $15K | — | Filing → |
| ZIOP | BUY | 2011-08-11 | $26K | — | Filing → |
| BDN | SELL | 2010-11-26 | $33K | — | Filing → |